April 4, 2022
Reachable Workspace to Evaluate Efficacy of Losmapimodin Subjects with FSHD in Two Phase 2 Studies
Rabi Tawil, MD, Kathryn Wagner, MD, PhD, Jeffrey Statland, MD, Leo Wang, MD, PhD, Angela Genge, MD, Sabrina Sacconi, MD, PhD, Hanns Lochmüller, MD, PhD, David Reyes Leiva, MD, Jordi Diaz-Manera, MD, PhD, Nuria Muelas, MD, PhD, Juan J. Vilchez, MD, PhD, Alan Pestronk, MD, Summer Gibson, MD, Namita A. Goyal, MD, Johanna Hamel, MD, Jay Han, MD, Lawrence Hayward, MD, Nicholas Johnson, MD, Samantha LoRusso, MD, Miriam Freimer, MD, Perry B. Shieh, MD, PhD, Sankarasubramoney H. Subramony, MD, Doris Leung MD, PhD, Baziel van Engelen MD, PhD, Joost Kools, MD, John Jiang, PhD, L. Alejandro Rojas, PhD, Anthony Accorsi, PhD,Christopher Morabito, MD, Jennifer Shoskes, PharmD, Michelle L. Mellion, MD (first author)
April 4, 2022
Whole Body MRI Quantitative muscle analysis to evaluate Efficacy of Losmapimodin a Phase 2 Placebo-Controlled Study in Subjects with FSHD (ReDUX4): ReDUX4 (NCT04003974)
Rabi Tawil, MD, Kathryn Wagner, MD, PhD, Jeffrey Statland, MD, Leo Wang, MD, PhD, Angela Genge, MD, Sabrina Sacconi, MD, PhD, Hanns Lochmüller, MD, PhD, David Reyes Leiva, MD, Jordi Diaz-Manera, MD, PhD, Jorge Alonso-Perez, MD, Nuria Muelas, MD, PhD, Juan J. Vilchez, MD, PhD, Alan Pestronk, MD, Summer Gibson, MD, Namita A. Goyal, MD, Johanna Hamel, MD, Lawrence Hayward, MD, Nicholas Johnson, MD, Samantha LoRusso, MD, Miriam Freimer, MD, Perry B. Shieh, MD, PhD, Sankarasubramoney H. Subramony, MD, Doris Leung MD, PhD, Baziel van Engelen MD, PhD, Joost Kools, MD, Olof Dahlqvist, Per Widholm, John Jiang, PhD, Adefowope Odueyungbo, PhD, William Tracewell, PhD, Alisa Rahilly, BSc, L. Alejandro Rojas, PhD, Anthony Accorsi, PhD, Steve Mennen, PhD, Lucienne Ronco, PhD, Diego Cadavid, MD, Christopher M. Moxham, PhD, Christopher Morabito, MD, Robert Gould, PhD, Michelle L. Mellion, MD.
March 16, 2022
Reachable Workspace to Evaluate Efficacy of Losmapimod in Subjects with FSHD in Two Phase 2 Studies
Joost Kools, Nicol Voermans, Karlien Mul, Baziel van Engelen, Michelle L. Mellion, John Jiang, Jennifer Shoskes, Kelly Marshall, David Jackson, Yuxi Zhao, Anil Tarachandani, Joanita Figueredo, Damien Eggenspieler
March 16, 2022
Feasibility of Measuring Functional Performance of FSHD Patients Using Wearable Sensors to Quantify Physical Activity
Joost Kools, Nicol Voermans, Karlien Mul, Baziel van Engelen, Michelle L. Mellion, John Jiang, Jennifer Shoskes, Kelly Marshall, David Jackson, Yuxi Zhao, Anil Tarachandani, Joanita Figueredo Damien Eggenspieler
March 16, 2022
An Open-Label Study of Losmapimod to Evaluate the Safety, Tolerability, and Biomarker and Clinical Outcome Assessment Changes in Subjects with FSHD1
Joost Kools, Nicol Voermans, Karlien Mul, Lucienne Ronco, John Jiang, Jennifer Shoskes, Kelly Marshall, Diego Cadavid, Michelle L. Mellion, Baziel van Engelen
December 1, 2021
Phase 1 clinical trial of losmapimod in facioscapulohumeral dystrophy: Safety, tolerability, pharmacokinetics, and target engagement
Mellion ML, L Ronco, CL Berends, L Pagan, S Brooks, MJ van Esdonk, EMJ van Brummelen, A Odueyungbo, LA Thompson, M Hage, UA Badrising, S Raines, WG Tracewell, B van Engelen, D Cadavid, GJ Groeneveld
September 23, 2021
An Open-Label Study of Losmapimod to Evaluate the Safety, Tolerability, and Biomarker and Clinical Outcome Assessment Changes in Subjects with FSHD1
Joost Kools, Nicol Voermans, KarlienMul, Lucienne Ronco, John Jiang, Jennifer Shoskes, Kelly Marshall, Diego Cadavid, Michelle L. Mellion, Baziel van Engelen
September 23, 2021
Quantitative Muscle Analysis in FSHD Using Whole-Body MRI: Composite Muscle Measurements for Cross-Sectional Analysis
Per Widholm, Markus Karlsson, André Ahlgren, Olof Dahlqvist-Leinhard, Rabi Tawil, Kathryn Wagner, Jeffrey Statland, Leo Wang, Perry Shieh, Baziel Van Engelen, Diego Cadavid, Lucienne Ronco, Adefowope Odueyungbo, Jay Han, Maya Hatch, Michelle L. Mellion
